In a temporary break from its corporate drama, Sinovac posted positive topline data from a phase 3 study of its chickenpox vaccine.

Here's some other vaccine news of note for this week.

Dynavax is assuming the daunting task of challenging a Big Pharma with a small internal team.

After a major cancer vaccine misstep, Bavarian Nordic reported positive six-week data from an ongoing phase 2 study on its RSV vaccine candidate.

Here's some other vaccine news of note for this week.

Johnson & Johnson and a U.S. development agency are zeroing in on pandemic flu in a novel deal focusing on vaccine and flu drug candidates.

Secretive Moderna shared a new peek into its infectious disease vaccines efforts Thursday.

Marking a big step in its march toward potential approval, GlaxoSmithKline’s shingles vaccine candidate Shingrix won the support of an FDA panel.

Vaccines